by Holly Wobma | Mar 22, 2017
For most areas of medicine, the supply of a treatment can easily meet demand (access issues aside). Need an antibody? A steroid? Millions of pills are manufactured every day. The case could not be more different for solid organ transplantation, for which the list of...
by Nicole Kuchinsky | Feb 8, 2017
In January, I attended Phacilitate’s Cell and Gene Therapy World in Miami, Florida. At this meeting industry leaders from around the world gather to discuss manufacturing, regulation and adoption of cell and gene therapies (C>). This was my first...
by Jovana Drinjakovic | Jan 16, 2017
Markus Grompe certainly thinks so and is working hard to make it happen. A scientist and a pediatrician specializing in inborn liver diseases, Dr. Grompe has a plan for overcoming the shortage of organ donors—the key obstacle for patients for whom the liver transplant...
by Hamideh Emrani | Dec 29, 2016
Professor Aaron Wheeler earned his PhD from Stanford University and, after a two-year postdoc fellowship at UCLA, joined the faculty of Chemistry at the University of Toronto. He has won numerous awards and honours for his work in the field of microfluidics and is the...
by Lisa Willemse | Nov 18, 2016
Stroke, lung damage and mathematical modeling. You may not think these three topics have much in common and for the most part you’d be right. But they have more than one common link. First, each is either a disease focus or methodology within stem cell research....
Comments